Anxious Patients Must be Alert in Pursuit of Expanded Access and Right-to-Try Strategies

When individuals with rare diseases or terminal illnesses do not meet the requirements for inclusion in a clinical trial that otherwise seems to offer hope for their condition, understanding the differences between the “expanded access” and “right-to-try” pathways to experimental medications may become a priority for both patients and their doctors. Comprehending the differences is […]

Congress Considering Law to Regulate High-Risk Diagnostic Tests

Legislation currently under consideration in the U.S. Congress would increase regulatory oversight of certain diagnostic tests, and a new study by researchers at Massachusetts General Hospital (MGH) and colleagues from several other institutions demonstrates that its potential impact will depend on key details in the bill’s final language. This study, published in JCO Oncology […]

ACRPtv—Spotlight On… ACRP’s Ride for Diversity

In this April 14, 2021 segment, cyclist Fisher discusses how he and co-rider Sergio Armani hope to raise more than $15,000 to help advance racial diversity in the clinical trial workforce with their bike ride from Pennsylvania to ACRP’s headquarters in Alexandria, VA in June.